← All trials
NCT03340350
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 10, 2017
- Primary completion
- Nov 30, 2018
- Completion date
- Nov 30, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 15
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Department of Veteran AffairsLead sponsor
- Department of Veteran AffairsOverall official - principal investigator
- Creighton UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.